In 2005, the discovery that somatic mutation in JAK2 exon 14 (JAK2 V617F) is presented in almost all the PV and half of the ET and PMF patients totally modified our understanding of these Philadelphia chromosome- (Ph-) negative MPNs [2–5]. Here, JAK2 is linked to acquired polycythemia vera.